Arcutis Biotherapeutics Inc (ARQT)
9.93
-0.54
(-5.16%)
USD |
NASDAQ |
Nov 14, 16:00
9.93
0.00 (0.00%)
Pre-Market: 08:44
Arcutis Biotherapeutics Free Cash Flow: -167.80M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -167.80M |
| June 30, 2024 | -177.02M |
| March 31, 2024 | -198.66M |
| December 31, 2023 | -247.48M |
| September 30, 2023 | -262.42M |
| June 30, 2023 | -309.03M |
| March 31, 2023 | -304.32M |
| December 31, 2022 | -281.00M |
| September 30, 2022 | -261.78M |
| June 30, 2022 | -212.15M |
| Date | Value |
|---|---|
| March 31, 2022 | -185.96M |
| December 31, 2021 | -175.62M |
| September 30, 2021 | -156.38M |
| June 30, 2021 | -149.16M |
| March 31, 2021 | -139.06M |
| December 31, 2020 | -113.35M |
| September 30, 2020 | -97.49M |
| June 30, 2020 | -74.42M |
| March 31, 2020 | -56.92M |
| December 31, 2019 | -43.13M |
Free Cash Flow Range, Past 5 Years
-309.03M
Minimum
Jun 2023
-43.13M
Maximum
Dec 2019
-180.66M
Average
-176.32M
Median
Free Cash Flow Benchmarks
| Mirum Pharmaceuticals Inc | -39.22M |
| Biogen Inc | 1.768B |
| Vertex Pharmaceuticals Inc | -1.352B |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -31.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.69M |
| Cash from Investing (Quarterly) | 84.78M |
| Cash from Financing (Quarterly) | 0.394M |
| Free Cash Flow Per Share (Quarterly) | -0.2802 |
| Free Cash Flow to Equity (Quarterly) | -35.63M |
| Free Cash Flow to Firm (Quarterly) | -28.18M |
| Free Cash Flow Yield | -14.84% |